Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Regadenoson | hsa00010 | Glycolysis / Gluconeogenesis | 4.41E-02 | 4 | P04075, P06733, P04406, P60174 | ALDOA, ENO1, GAPDH, TPI1 | More | | Regadenoson | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Regadenoson | hsa00051 | Fructose and mannose metabolism | 2.21E-02 | 3 | O14772, P60174, P04075 | FPGT, TPI1, ALDOA | More | | Regadenoson | hsa00052 | Galactose metabolism | 5.00E-02 | 1 | P35557 | GCK | More | | Regadenoson | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Regadenoson | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 1.27E-02 | 1 | P35557 | GCK | More | | Regadenoson | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Regadenoson | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Regadenoson | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Regadenoson | hsa00630 | Glyoxylate and dicarboxylate metabolism | 5.34E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Regadenoson | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Regadenoson | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Regadenoson | hsa01200 | Carbon metabolism | 6.24E-04 | 10 | P04075, P51854, P04406, P60174, P37837, P06733, O14521, Q9P2R7, P60891, Q02252 | ALDOA, TKTL1, GAPDH, TPI1, TALDO1, ENO1, SDHD, SUCLA2, PRPS1, ALDH6A1 | More | | Regadenoson | hsa01230 | Biosynthesis of amino acids | 6.53E-04 | 8 | P60174, P04406, P06733, P04075, P51854, P60891, Q99707, P37837 | TPI1, GAPDH, ENO1, ALDOA, TKTL1, PRPS1, MTR, TALDO1 | More | | Regadenoson | hsa01524 | Platinum drug resistance | 1.79E-02 | 2 | O15392, P11388 | BIRC5, TOP2A | More | | Regadenoson | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Regadenoson | hsa03013 | RNA transport | 3.98E-02 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Regadenoson | hsa03018 | RNA degradation | 5.00E-02 | 1 | Q9NQT4 | EXOSC5 | More | | Regadenoson | hsa03020 | RNA polymerase | 3.00E-02 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Regadenoson | hsa03040 | Spliceosome | 8.05E-04 | 9 | Q14562, O43143, O60508, P08579, Q07955, Q01130, Q13243, P11142, O43447 | DHX8, DHX15, CDC40, SNRPB2, SFRS1, SFRS2, SFRS5, HSPA8, PPIH | More | | Regadenoson | hsa03050 | Proteasome | 1.21E-02 | 1 | P28074 | PSMB5 | More | | Regadenoson | hsa03060 | Protein export | 4.42E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Regadenoson | hsa04020 | Calcium signaling pathway | 9.34E-03 | 7 | P27987, P21796, P45880, Q13557, P19174, P0DP23, P05141 | ITPKB, VDAC1, VDAC2, CAMK2D, PLCG1, CALM1, SLC25A5 | More | | Regadenoson | hsa04022 | cGMP-PKG signaling pathway | 2.26E-03 | 8 | Q14814, Q99941, P18848, P05141, P21796, P45880, P0DP23, P01042 | MEF2D, CREBL1, ATF4, SLC25A5, VDAC1, VDAC2, CALM1, KNG1 | More | | Regadenoson | hsa04064 | NF-kappa B signaling pathway | 2.35E-02 | 4 | P01584, P63279, Q8NHW4, Q9NQC7 | IL1B, UBE2I, CCL4L2, CYLD | More | | Regadenoson | hsa04070 | Phosphatidylinositol signaling system | 1.32E-02 | 5 | P19174, P0DP23, O14986, P23743, P27987 | PLCG1, CALM1, PIP5K1B, DGKA, ITPKB | More | | Regadenoson | hsa04071 | Sphingolipid signaling pathway | 8.10E-04 | 7 | P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Regadenoson | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | | Regadenoson | hsa04141 | Protein processing in endoplasmic reticulum | 6.42E-03 | 8 | P18848, P30101, Q15437, Q15436, Q99941, P11142, P07900, P08238 | ATF4, PDIA3, SEC23B, SEC23A, CREBL1, HSPA8, HSP90AA1, HSP90AB1 | More | | Regadenoson | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | | Regadenoson | hsa04144 | Endocytosis | 1.67E-02 | 8 | P0DMV8, Q9H444, O75351, P62491, Q96B97, Q15438, Q14161, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SH3KBP1, PSCD1, GIT2, SNX12 | More | | Regadenoson | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Regadenoson | hsa04151 | PI3K-Akt signaling pathway | 1.24E-02 | 12 | P62753, P27348, P07900, P08238, P62873, P63218, Q16363, P22105, P14784, Q99941, P18848, P30279 | RPS6, YWHAQ, HSP90AA1, HSP90AB1, GNB1, GNG5, LAMA4, TNXB, IL2RB, CREBL1, ATF4, CCND2 | More | | Regadenoson | hsa04213 | Longevity regulating pathway - multiple species | 2.82E-02 | 3 | Q08828, P51828, P0DMV8 | ADCY1, ADCY7, HSPA1A | More | | Regadenoson | hsa04217 | Necroptosis | 9.97E-03 | 8 | P42224, P07900, P08238, P15104, P05141, Q13557, P21796, P45880 | STAT1, HSP90AA1, HSP90AB1, GLUL, SLC25A5, CAMK2D, VDAC1, VDAC2 | More | | Regadenoson | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.95E-02 | 4 | P07550, P22694, P18848, Q13362 | ADRB2, PRKACB, ATF4, PPP2R5C | More | | Regadenoson | hsa04270 | Vascular smooth muscle contraction | 6.96E-03 | 6 | P0DP23, Q08828, P51828, P35579, P35749, P35318 | CALM1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Regadenoson | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Regadenoson | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Regadenoson | hsa04612 | Antigen processing and presentation | 1.07E-03 | 6 | Q14953, P26715, P26717, Q13241, P01732, P01375 | KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Regadenoson | hsa04613 | Neutrophil extracellular trap formation | 6.68E-04 | 17 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q93077, P62807, O60814, P68431, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Regadenoson | hsa04623 | Cytosolic DNA-sensing pathway | 1.65E-02 | 2 | P01584, Q8NHW4 | IL1B, CCL4L2 | More | | Regadenoson | hsa04650 | Natural killer cell mediated cytotoxicity | 5.05E-04 | 7 | P01375, P20963, Q13241, P26718, P26717, Q14953, P26715 | TNF, CD247, KLRD1, KLRK1, KLRC2, KIR2DS5, KLRC1 | More | | Regadenoson | hsa04657 | IL-17 signaling pathway | 4.27E-03 | 7 | O00463, Q16539, P19875, P14780, Q9UJX4, P80188, P01375 | TRAF5, MAPK14, CXCL2, MMP9, ANAPC5, LCN2, TNF | More | | Regadenoson | hsa04659 | Th17 cell differentiation | 3.71E-02 | 6 | P19174, P42224, P14784, P07900, P08238, P07766 | PLCG1, STAT1, IL2RB, HSP90AA1, HSP90AB1, CD3E | More | | Regadenoson | hsa04662 | B cell receptor signaling pathway | 1.49E-03 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Regadenoson | hsa04664 | Fc epsilon RI signaling pathway | 2.32E-02 | 3 | P42338, P07948, P09917 | PIK3CB, LYN, ALOX5 | More | | Regadenoson | hsa04668 | TNF signaling pathway | 3.55E-02 | 4 | P01375, P18848, P19875, P14780 | TNF, ATF4, CXCL2, MMP9 | More | | Regadenoson | hsa04713 | Circadian entrainment | 4.76E-02 | 4 | P0DP23, Q13557, P62873, P63218 | CALM1, CAMK2D, GNB1, GNG5 | More | | Regadenoson | hsa04721 | Synaptic vesicle cycle | 3.77E-02 | 1 | P43003 | SLC1A3 | More | | Regadenoson | hsa04724 | Glutamatergic synapse | 5.94E-03 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | | Regadenoson | hsa04725 | Cholinergic synapse | 5.23E-03 | 6 | P62873, P63218, P50151, P18848, Q13557, P42338 | GNB1, GNG5, GNG10, ATF4, CAMK2D, PIK3CB | More | | Regadenoson | hsa04727 | GABAergic synapse | 2.26E-03 | 5 | P62873, P63218, P50151, P15104, P46459 | GNB1, GNG5, GNG10, GLUL, NSF | More | | Regadenoson | hsa04728 | Dopaminergic synapse | 1.87E-02 | 6 | P62873, P63218, Q99941, P18848, Q13557, P0DP23 | GNB1, GNG5, CREBL1, ATF4, CAMK2D, CALM1 | More | | Regadenoson | hsa04740 | Olfactory transduction | 9.79E-03 | 3 | P62873, Q13557, P0DP23 | GNB1, CAMK2D, CALM1 | More | | Regadenoson | hsa04744 | Phototransduction | 1.42E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Regadenoson | hsa04750 | Inflammatory mediator regulation of TRP channels | 1.73E-03 | 8 | P01584, Q08828, P51828, Q13557, P19174, P24723, P0DP23, P01042 | IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PRKCH, CALM1, KNG1 | More | | Regadenoson | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Regadenoson | hsa04915 | Estrogen signaling pathway | 1.27E-03 | 10 | Q99941, P18848, Q08828, P51828, P07900, P08238, P0DMV8, P11142, P0DP23, Q15788 | CREBL1, ATF4, ADCY1, ADCY7, HSP90AA1, HSP90AB1, HSPA1A, HSPA8, CALM1, NCOA1 | More | | Regadenoson | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | | Regadenoson | hsa04925 | Aldosterone synthesis and secretion | 3.35E-02 | 4 | Q99941, P18848, P0DP23, Q13557 | CREBL1, ATF4, CALM1, CAMK2D | More | | Regadenoson | hsa04926 | Relaxin signaling pathway | 3.93E-04 | 9 | P42338, P63218, P50151, P18848, P22694, P49767, P14780, P30679, P49407 | PIK3CB, GNG5, GNG10, ATF4, PRKACB, VEGFC, MMP9, GNA15, ARRB1 | More | | Regadenoson | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | | Regadenoson | hsa04929 | GnRH secretion | 4.62E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Regadenoson | hsa04932 | Non-alcoholic fatty liver disease | 1.39E-02 | 6 | O43521, O75460, P01584, P13073, P12074, O95298 | BCL2L11, ERN1, IL1B, COX4I1, COX6A1, NDUFC2 | More | | Regadenoson | hsa04950 | Maturity onset diabetes of the young | 1.27E-02 | 1 | P35557 | GCK | More | | Regadenoson | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Regadenoson | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Regadenoson | hsa04970 | Salivary secretion | 2.43E-03 | 6 | P07550, Q08828, P51828, P22694, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, CALM1, CAMP | More | | Regadenoson | hsa04976 | Bile secretion | 4.78E-02 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | | Regadenoson | hsa05010 | Alzheimer disease | 4.56E-02 | 9 | P19404, P13073, P0DP23, P18848, Q71U36, Q13509, P05141, P21796, P45880 | NDUFV2, COX4I1, CALM1, ATF4, TUBA1A, TUBB3, SLC25A5, VDAC1, VDAC2 | More | | Regadenoson | hsa05012 | Parkinson disease | 6.70E-04 | 11 | P19404, P13073, P05141, P21796, P45880, P18848, P19174, P0DP23, Q13557, Q71U36, Q13509 | NDUFV2, COX4I1, SLC25A5, VDAC1, VDAC2, ATF4, PLCG1, CALM1, CAMK2D, TUBA1A, TUBB3 | More | | Regadenoson | hsa05016 | Huntington disease | 6.33E-04 | 16 | O95298, P19404, P13073, P12074, Q13547, P24928, P30876, P62487, P05141, P21796, P45880, O75460, Q71U36, Q13509, P28070, O00232 | NDUFC2, NDUFV2, COX4I1, COX6A1, HDAC1, POLR2A, POLR2B, POLR2G, SLC25A5, VDAC1, VDAC2, ERN1, TUBA1A, TUBB3, PSMB4, PSMD12 | More | | Regadenoson | hsa05017 | Spinocerebellar ataxia | 2.43E-02 | 1 | P28074 | PSMB5 | More | | Regadenoson | hsa05020 | Prion disease | 9.64E-03 | 10 | P11142, P19404, P13073, P18848, P05141, P21796, P45880, Q71U36, Q13509, Q99941 | HSPA8, NDUFV2, COX4I1, ATF4, SLC25A5, VDAC1, VDAC2, TUBA1A, TUBB3, CREBL1 | More | | Regadenoson | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.36E-02 | 12 | Q71U36, Q13509, P19404, P13073, P21796, P18848, P19174, P05141, P45880, P20333, P0DP23, Q13557 | TUBA1A, TUBB3, NDUFV2, COX4I1, VDAC1, ATF4, PLCG1, SLC25A5, VDAC2, TNFRSF1B, CALM1, CAMK2D | More | | Regadenoson | hsa05031 | Amphetamine addiction | 7.46E-04 | 6 | P0DP23, Q13557, P22694, Q99941, P18848, Q13547 | CALM1, CAMK2D, PRKACB, CREBL1, ATF4, HDAC1 | More | | Regadenoson | hsa05034 | Alcoholism | 2.40E-04 | 10 | Q99941, P18848, Q13547, P0DP23, P62873, P63218, Q93077, P62807, O60814, P68431 | CREBL1, ATF4, HDAC1, CALM1, GNB1, GNG5, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Regadenoson | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Regadenoson | hsa05134 | Legionellosis | 2.27E-03 | 7 | P01584, Q9NR31, P11215, P68104, P0DMV8, P11142, P19875 | IL1B, SAR1A, ITGAM, EEF1A1, HSPA1A, HSPA8, CXCL2 | More | | Regadenoson | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Regadenoson | hsa05144 | Malaria | 1.44E-03 | 5 | P69905, P68871, P01375, P35443, P26718 | HBA2, HBB, TNF, THBS4, KLRK1 | More | | Regadenoson | hsa05146 | Amoebiasis | 2.41E-02 | 4 | P19875, P01375, P30679, P22694 | CXCL2, TNF, GNA15, PRKACB | More | | Regadenoson | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Regadenoson | hsa05163 | Human cytomegalovirus infection | 3.31E-02 | 7 | P0DP23, Q8NHW4, Q08828, P51828, P23458, P01584, Q13651 | CALM1, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, IL10RA | More | | Regadenoson | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.15E-02 | 7 | P42224, P62873, P63218, P19875, P19174, P07948, P0DP23 | STAT1, GNB1, GNG5, CXCL2, PLCG1, LYN, CALM1 | More | | Regadenoson | hsa05169 | Epstein-Barr virus infection | 4.48E-03 | 9 | Q13547, P42338, P07948, P30101, Q13761, O75293, P30279, P42224, P07766 | HDAC1, PIK3CB, LYN, PDIA3, RUNX3, GADD45B, CCND2, STAT1, CD3E | More | | Regadenoson | hsa05200 | Pathways in cancer | 1.93E-03 | 17 | Q16363, P07900, P08238, P42224, P19174, P43246, P20585, Q13547, P30279, P62873, P63218, P78417, O75293, P0DP23, Q13557, P14784, P01042 | LAMA4, HSP90AA1, HSP90AB1, STAT1, PLCG1, MSH2, MSH3, HDAC1, CCND2, GNB1, GNG5, GSTO1, GADD45B, CALM1, CAMK2D, IL2RB, KNG1 | More | | Regadenoson | hsa05202 | Transcriptional misregulation in cancer | 1.45E-02 | 12 | Q15532, P41732, P14780, P27930, P14923, Q16548, Q13077, O15550, P35226, P05164, P08246, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, TRAF1, UTX, BMI1, MPO, ELA2, GADD45A | More | | Regadenoson | hsa05203 | Viral carcinogenesis | 4.09E-04 | 12 | Q99941, P18848, P06746, P07948, P30279, P27348, P29083, Q7KZF4, Q13547, Q15283, P62807, O60814 | CREBL1, ATF4, POLB, LYN, CCND2, YWHAQ, GTF2E1, SND1, HDAC1, RASA2, HIST1H2BC, H2BC12 | More | | Regadenoson | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Regadenoson | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | | Regadenoson | hsa05214 | Glioma | 1.76E-02 | 4 | P0DP23, Q13557, P19174, O75293 | CALM1, CAMK2D, PLCG1, GADD45B | More | | Regadenoson | hsa05321 | Inflammatory bowel disease | 1.91E-02 | 3 | P01375, Q14765, Q9UL17 | TNF, STAT4, TBX21 | More | | Regadenoson | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Regadenoson | hsa05332 | Graft-versus-host disease | 8.79E-03 | 3 | P01375, P26715, Q13241 | TNF, KLRC1, KLRD1 | More | | Regadenoson | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | |